Nuo Therapeutics, Inc.
AURX
$1.63
$0.00460.28%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 316.40K | 55.70K | 283.70K | 683.80K | 473.00K |
Total Receivables | 320.40K | 276.50K | 248.20K | 329.20K | 305.00K |
Inventory | 165.80K | 99.20K | 150.40K | 167.80K | 216.80K |
Prepaid Expenses | 50.70K | 170.10K | 159.20K | 161.90K | 179.70K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 853.30K | 601.50K | 841.50K | 1.34M | 1.17M |
|
|||||
Total Current Assets | 853.30K | 601.50K | 841.50K | 1.34M | 1.17M |
Net Property, Plant & Equipment | 506.20K | 545.20K | 348.00K | 376.30K | 245.90K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 1.36M | 1.15M | 1.19M | 1.72M | 1.42M |
|
|||||
Total Accounts Payable | 312.90K | 662.10K | 219.20K | 385.40K | 397.60K |
Total Accrued Expenses | 314.60K | 349.60K | 292.40K | 264.00K | 230.30K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 71.50K | 69.20K | 66.90K | 64.60K | 62.40K |
Total Finance Division Other Current Liabilities | 300.00K | 200.00K | -- | -- | -- |
Total Other Current Liabilities | 300.00K | 200.00K | -- | -- | -- |
Total Current Liabilities | 999.00K | 1.28M | 578.50K | 714.00K | 690.40K |
|
|||||
Total Current Liabilities | 999.00K | 1.28M | 578.50K | 714.00K | 690.40K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 60.10K | 78.90K | 97.30K | 114.70K | 131.60K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.13M | -- | -- | -- | -- |
Total Liabilities | 2.18M | 1.36M | 675.80K | 828.70K | 822.00K |
|
|||||
Common Stock & APIC | 32.83M | 32.79M | 32.77M | 32.65M | 31.78M |
Retained Earnings | -33.66M | -33.01M | -32.26M | -31.76M | -31.19M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -824.60K | -213.10K | 513.70K | 890.40K | 598.50K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -824.60K | -213.10K | 513.70K | 890.40K | 598.50K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -824.60K | -213.10K | 513.70K | 890.40K | 598.50K |
|